Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Defying Trends: How Agenda Health is Achieving Record-Breaking Success in a Challenging Market
Healthcare M&A activity has been facing a decline in recent years, a trend highlighted by data captured in the LevinPro HC database. During the first three quarters of 2024, 1,101 healthcare services deals were announced—a drop of nearly 8% compared to the 1,191 deals recorded during the same period in 2023, and an 18% decline from the 1,340 deals completed in the first three quarters of 2022, which was a record-breaking year for healthcare M&A. Across all healthcare verticals, including the healthcare technology sectors, the total number of deals in the first three quarters of 2024 stood at 1,510, reflecting a more than 10% decrease from the 2023 figures, and a nearly 20% drop... Read More »
McLaren Health Care Acquires Park Medical Centers
On November 25, McLaren Health Care announced that it acquired Park Medical Centers for an undisclosed price. Park Medical Centers is a group of 10 primary care health clinics heavily concentrated in communities throughout Wayne, Oakland and Macomb counties in Michigan. According to the press release, there are 21 providers on staff that serve 36,000 patients. McLaren Health Care is a fully integrated health network comprising 15 hospitals in Michigan and Ohio, a 490-member employed primary and specialty care physician network, outpatient centers, home health and hospice services and medical plans covering more than 588,000 lives in Michigan and Indiana. “Park... Read More »
Arlington Capital Partners Acquires TEAM Technologies
Arlington Capital Partners, a private equity firm based in Washington, D.C., announced on November 25 that it entered into an agreement to acquire TEAM Technologies. TEAM Technologies is a design and manufacturing partner to many of the world’s leading brands in the dental, medical and cosmetic industries. TEAM Tech is a leading provider of specialized manufacturing and strategic supply chain solutions to blue-chip healthcare customers. It was sold by Clearlake Capital Group, L.P., a private equity group based in Santa Monica, California. Before Clearlake purchased the company in 2018, TEAM was owned by The Riverside Company, a private equity firm based in New York... Read More »
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced on November 25 that it has entered into a definitive agreement to acquire Newton, Massachusetts-based Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine – a chemotherapy drug – both of which are approved by the U.S. Food and Drug Administration. The Intera 3000 pump is used to administer hepatic artery infusion therapy to treat tumors in the liver primarily caused by metastatic colorectal cancer. Boston Scientific develops and manufactures minimally invasive medical devices used in interventional cardiology, cardiac rhythm management, peripheral... Read More »
Health Advocates Augments Radiology Staffing Offerings With DiagnosTemps Acquisition
On November 25, 2024, Health Advocates Network, Inc. announced the acquisition of DiagnosTemps, a radiology staffing agency specializing in the placement of radiology professionals to healthcare facilities across the United States. DiagnosTemps was established in 1993 and headquartered in Dallas, Texas. Health Advocates Network specializes in healthcare staffing solutions, providing a range of services within the healthcare sector. The company was founded in 2020 and is based in Boca Raton, Florida. DiagnosTemps will continue to operate as a separate unit under the DiagnosTemps Joint Commission certified brand. Financial terms of the deal were not disclosed. The DiagnosTemps transaction... Read More »
Virtua Health Acquires Christiana Spine Ambulatory Surgical Center
On November 20, Merritt Healthcare Advisors, a provider of M&A consultative services for healthcare organizations nationwide, announced that Virtua Health was acquiring Christiana Spine Ambulatory Surgical Center (CSASC). CSASC is an ambulatory surgery center (ASC) in Newark, Delaware. The ASC specializes in spine surgery, diagnostics treatments, minimally invasive spine surgery and non-surgical treatments. Virtua Medical Group is an academic health system that provides a full spectrum of health care services. In addition to joint ventures with 42 ambulatory surgery centers in New Jersey, Pennsylvania and Delaware, Virtua operates five hospitals in Southern New Jersey and has... Read More »
Summit Spine & Joint Centers Acquires Integrated Pain Solutions
On November 19, Summit Spine & Joint Centers announced that it acquired Integrated Pain Solutions (IPS) for an undisclosed amount. IPS is a pain management practice with 11 locations in North Carolina. According to its website, the practice has two board-certified medical directors on staff: Drs. Thomas Bresly and Todd Reiter. They are supported by a team of 16 employees. Backed by MSouth Equity Partners, Summit Spine & Joint Centers is a management services organization that provides administrative and support services to its network of clinics and ambulatory surgery centers across the Southeast. The company’s footprint includes 41 locations across... Read More »
Epiphany Dermatology Acquires George Dermatology
Epiphany Dermatology, a portfolio company of the private equity firm CI Capital Partners, recently announced that it acquired George Dermatology. Based in St. Louis, Missouri, George Dermatology is run by Dr. Mary Noel George. According to the press release, Dr. George is the only physician on staff, but she is supported by a team of employees. Epiphany provides general dermatology, skin cancer care, Mohs surgery, cosmetic services and additional dermatologic services. It has partnerships with dermatologists in more than 90 locations across Arizona, Colorado, Georgia, Iowa, Kansas, Minnesota, Missouri, Montana, New Mexico, Oklahoma, South Carolina, Texas and... Read More »
Novartis Acquires Kate Therapeutics for up to $1.1 Billion
Novartis announced on November 21 that it has acquired Kate Therapeutics to further enhance and strengthen its ongoing efforts to advance gene therapies for patients. Under the terms of the agreement, Kate Therapeutics’ shareholders are entitled to receive up to $1.1 billion, in a combination of upfront cash and potential milestone payments. The exact amount of the upfront payment was not disclosed. San Diego-based Kate Therapeutics is a patient-focused biotechnology company developing adeno-associated virus-based gene therapies to treat genetically defined muscle and heart diseases. Kate is focused on preclinical programs aimed at Duchenne muscular dystrophy,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
